Cargando…

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

BACKGROUND & AIMS: We aimed to evaluate the impact of oesophageal varices (OV) and their evolution on the risk of complications of compensated advanced chronic liver disease (cACLD) caused by non-alcoholic fatty liver disease (NAFLD). We also assessed the accuracy of non-invasive scores for pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pennisi, Grazia, Enea, Marco, Viganò, Mauro, Schepis, Filippo, de Ledinghen, Victor, Berzigotti, Annalisa, Wai-Sun Wong, Vincent, Fracanzani, Anna Ludovica, Sebastiani, Giada, Lara-Romero, Carmen, Bugianesi, Elisabetta, Svegliati-Baroni, Gianluca, Marra, Fabio, Aghemo, Alessio, Valenti, Luca, Calvaruso, Vincenza, Colecchia, Antonio, Di Maria, Gabriele, La Mantia, Claudia, Lin, Huapeng, Mendoza, Yuly P., Pugliese, Nicola, Ravaioli, Federico, Romero-Gomez, Manuel, Saltini, Dario, Craxì, Antonio, Di Marco, Vito, Cammà, Calogero, Petta, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393808/ https://www.ncbi.nlm.nih.gov/pubmed/37538247 http://dx.doi.org/10.1016/j.jhepr.2023.100809

Ejemplares similares

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis
por: Turola, Elena, et al.
Publicado: (2015)

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease
por: Pennisi, Grazia, et al.
Publicado: (2022)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development
por: Pipitone, Rosaria Maria, et al.
Publicado: (2022)

Serum γ-glutamyl Transferase Levels, Insulin Resistance and Liver Fibrosis in Patients with Chronic Liver Diseases
por: Petta, Salvatore, et al.
Publicado: (2012)

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)

NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
por: Licata, Anna, et al.
Publicado: (2013)

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
por: Calvaruso, Vincenza, et al.
Publicado: (2021)

Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives
por: Saltini, Dario, et al.
Publicado: (2023)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2013)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
por: Petta, Salvatore, et al.
Publicado: (2012)

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation
por: Lasagni, Simone, et al.
Publicado: (2022)

Heart rate variability is associated with disease severity and portal hypertension in cirrhosis
por: Miceli, Giuseppe, et al.
Publicado: (2023)

Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2015)

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study
por: Riggio, Oliviero, et al.
Publicado: (2023)

Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years
por: Di Biase, Anna Rita, et al.
Publicado: (2021)

Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area
por: Mocchegiani, Federico, et al.
Publicado: (2020)

Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
por: Dajti, Elton, et al.
Publicado: (2021)

Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases
por: Mendoza, Yuly P., et al.
Publicado: (2021)

Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease
por: Ravaioli, Federico, et al.
Publicado: (2022)

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
por: Donati, Benedetta, et al.
Publicado: (2017)

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity
por: Di Mauro, Stefania, et al.
Publicado: (2019)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome
por: Dajti, Elton, et al.
Publicado: (2019)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
por: Mori, Hideki, et al.
Publicado: (2022)

A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
por: Marasco, Giovanni, et al.
Publicado: (2021)

Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
por: Calvaruso, Vincenza, et al.
Publicado: (2013)

Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives
por: Casciola, Riccardo, et al.
Publicado: (2023)

Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response
por: Cabibbo, Giuseppe, et al.
Publicado: (2013)

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease
por: Bayoumi, Ali, et al.
Publicado: (2020)

Microtubule-based actin transport and localization in a spherical cell
por: Saltini, Marco, et al.
Publicado: (2020)

A plausible mechanism for longitudinal lock-in of the plant cortical microtubule array after light-induced reorientation
por: Saltini, Marco, et al.
Publicado: (2021)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients
por: Ravaioli, Federico, et al.
Publicado: (2023)

Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
por: Bonifazi, Francesca, et al.
Publicado: (2020)

Hepatitis C: Standard of Treatment and What to Do for Global Elimination
por: Di Marco, Lorenza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kj22j3h117j79koe4uf8fhe884